In an unparalleled move, the corporate world is making headlines with its most significant push in favor of cannabis to date. This effort could be the game-changer in the ongoing battle for drug policy reform.

Historically, the narrative has been dominated by powerful lobbying against cannabis, backed by hundreds of millions of dollars spanning over half a century. In stark contrast, this new coalition promises to bring balance to the debate, giving cannabis advocates a louder, unified voice in policy circles.

High-profile conservative leaders, such as Mitch McConnell, have long been known to receive funds from groups campaigning vigorously against cannabis reforms. These policy groups have a vested interest, as their patrons thrive on the illegal status of cannabis. They have actively drafted and advocated for legislation that ensures cannabis remains off the legal shelves.

However, winds of change are blowing. A lawsuit is currently underway that challenges the federal government’s enforcement of the Controlled Substances Act, specifically when it clashes with state-sanctioned cultivation, manufacture, and distribution of cannabis. The lawsuit’s bold stance? The federal government lacks grounds to intervene in state-regulated cannabis operations.